Siloam International Hospitals Tbk PT
IDX:SILO

Watchlist Manager
Siloam International Hospitals Tbk PT Logo
Siloam International Hospitals Tbk PT
IDX:SILO
Watchlist
Price: 3 030 IDR 1% Market Closed
Market Cap: 39.4T IDR
Have any thoughts about
Siloam International Hospitals Tbk PT?
Write Note
Section:
 

Relative Value

The Relative Value of one SILO stock under the Base Case scenario is 3 190.9 IDR. Compared to the current market price of 3 030 IDR, Siloam International Hospitals Tbk PT is Undervalued by 5%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SILO Relative Value
Base Case
3 190.9 IDR
Undervaluation 5%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.3
P/S
P/S
Price to Sales
3.3
vs History
3
vs Industry
40
Median 3Y
2.2
Median 5Y
1.5
Industry
2.3
Forward
3.1
More Details
39.8
P/E
P/E
Price to Earnings
39.8
vs History
11
vs Industry
15
Median 3Y
24.5
Median 5Y
23.8
Industry
23.1
Forward
33.7
More Details
16.3
P/OCF
P/OCF
Price to OCF
16.3
vs History
4
vs Industry
24
Median 3Y
13.2
Median 5Y
8.7
Industry
14.2
More Details
198
P/FCFE
P/FCFE
Price to FCFE
198
vs History
12
vs Industry
2
Median 3Y
71.4
Median 5Y
23.6
Industry
20.1
More Details
4.8
P/B
P/B
Price to Book Value
4.8
vs History
3
vs Industry
19
Median 3Y
3.1
Median 5Y
2.2
Industry
2.2
More Details
3.2
EV/S
EV/S
Enterprise Value to Sales
3.2
vs History
3
vs Industry
38
Median 3Y
2.2
Median 5Y
1.4
Industry
2.4
Forward
3
More Details
8.1
EV/GP
EV/GP
Enterprise Value to Gross Profit
8.1
vs History
3
vs Industry
29
Median 3Y
5.7
Median 5Y
4
Industry
5
More Details
22.6
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
22.6
vs History
6
vs Industry
15
Median 3Y
16.4
Median 5Y
14.8
Industry
12.7
Forward
13.1
More Details
22.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
22.6
vs History
6
vs Industry
20
Median 3Y
16.4
Median 5Y
14.8
Industry
17.1
Forward
18.6
More Details
16.1
EV/OCF
EV/OCF
Enterprise Value to OCF
16.1
vs History
4
vs Industry
25
Median 3Y
12.6
Median 5Y
8
Industry
14
More Details
53
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
53
vs History
12
vs Industry
4
Median 3Y
32
Median 5Y
13.5
Industry
18
More Details
3.9
EV/IC
EV/IC
Enterprise Value to IC
3.9
vs History
3
vs Industry
23
Median 3Y
2.6
Median 5Y
1.7
Industry
1.9
More Details

Multiples Across Competitors

SILO Competitors Multiples
Siloam International Hospitals Tbk PT Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
ID
Siloam International Hospitals Tbk PT
IDX:SILO
39.3T IDR 3.3 39.8 22.6 22.6
US
HCA Healthcare Inc
NYSE:HCA
78.3B USD 1.1 13.3 8.3 10.9
SA
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
98B SAR 9.3 44 39 45.3
ZA
Life Healthcare Group Holdings Ltd
JSE:LHC
24.1B Zac 0 0 0 0
ZA
Netcare Ltd
JSE:NTC
20B Zac 0 0 0 0
CN
Aier Eye Hospital Group Co Ltd
SZSE:300015
129.8B CNY 6.3 35.8 27.1 27.1
MY
IHH Healthcare Bhd
KLSE:IHH
63.4B MYR 2.7 23.9 12.9 18.7
IN
Max Healthcare Institute Ltd
NSE:MAXHEALTH
1.1T INR 19.8 106.6 74.1 88.3
US
Tenet Healthcare Corp
NYSE:THC
12.4B USD 0.6 3.9 5.2 6.6
IN
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
1T INR 5.3 100.7 42 57.5
US
Universal Health Services Inc
NYSE:UHS
12B USD 0.8 11.7 7.8 10.7

See Also

Summary
SILO intrinsic value, competitors valuation, and company profile.
DCF Valuation
SILO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SILO stock valuation using valuation multiples.
Wall Street Estimates
SILO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SILO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 211,100+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.